A Phase 3, Prospective, Randomized, Double-masked, Placebo-controlled, Parallel-design, Multicenter Study to Evaluate the Efficacy and Safety of DEXYCU for the Treatment of Ocular Pain Associated With Cataract Surgery
Latest Information Update: 26 Sep 2022
At a glance
- Drugs Dexamethasone (Primary)
- Indications Ocular pain
- Focus Registrational; Therapeutic Use
- Sponsors EyePoint Pharmaceuticals
Most Recent Events
- 26 Sep 2022 New trial record